Acanthosis nigricans in obese Chinese children

H Y Ng1, Jack H M Young1, K F Huen1

  • 1Department of Paediatrics and Adolescent Medicine, Tseung Kwan O Hospital, Tseung Kwan O, Hong Kong.

Insights

Acanthosis nigricans in obese Chinese children is linked to higher rates of insulin resistance and other cardiometabolic issues. Early detection of this skin condition is crucial for timely intervention in pediatric obesity.

Area of Science:

  • Pediatric Endocrinology
  • Dermatology
  • Metabolic Syndrome

Background:

  • Obesity is a growing concern in children, increasing the risk of metabolic complications.
  • Acanthosis nigricans, a skin condition, is often associated with insulin resistance.
  • Understanding these associations in Chinese pediatric populations is important for public health.

Purpose of the Study:

  • To examine demographic factors and insulin resistance in overweight/obese Chinese children.
  • To investigate the link between acanthosis nigricans and insulin resistance.
  • To explore associations of acanthosis nigricans with cardiometabolic comorbidities in this group.

Main Methods:

  • Cross-sectional analysis of 543 overweight/obese Chinese children from Hong Kong (2006-2010).
  • Data collected included demographics, anthropometrics, acanthosis nigricans status, and biochemical markers.
  • Statistical analysis compared groups with and without acanthosis nigricans and assessed correlations.

Main Results:

  • 29% of participants had insulin resistance; adolescents and obese children were more likely to have it.
  • Children with acanthosis nigricans showed significantly higher blood pressure, glucose, insulin, HOMA-IR, triglycerides, and ALT levels.
  • Acanthosis nigricans was associated with higher odds of insulin resistance, hypertension, fatty liver, and abnormal glucose homeostasis.

Conclusions:

  • Obese Chinese children with acanthosis nigricans have an increased risk of insulin resistance and cardiometabolic diseases.
  • Acanthosis nigricans serves as a critical clinical indicator for early identification of metabolic dysfunction.
  • Prompt evaluation and intervention are recommended for children presenting with acanthosis nigricans.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324